The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 2, Pages 217
Publisher
MDPI AG
Online
2021-01-11
DOI
10.3390/cancers13020217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling
- (2020) A. Romano et al. Scientific Reports
- Immunogenomic identification and characterization of granulocytic myeloid derived suppressor cells in multiple myeloma
- (2020) Cristina Perez et al. BLOOD
- Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma
- (2020) Nouf Alrasheed et al. CLINICAL CANCER RESEARCH
- Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
- (2020) Rui Yang et al. Journal for ImmunoTherapy of Cancer
- Cancer immunoediting and immune dysregulation in multiple myeloma
- (2020) Kyohei Nakamura et al. BLOOD
- MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
- (2020) Qiang Wang et al. BLOOD
- Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma
- (2020) Saeko Kuwahara‐Ota et al. BRITISH JOURNAL OF HAEMATOLOGY
- PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model
- (2020) Byung-Hyun Lee et al. Scientific Reports
- CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages
- (2020) Ole Audun W. Haabeth et al. Blood Advances
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Haematopoietic stem cell activity and interactions with the niche
- (2019) Sandra Pinho et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Evaluating the role of Tregs in the progression of multiple myeloma
- (2019) Deepesh Lad et al. LEUKEMIA & LYMPHOMA
- Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
- (2019) Harmen van Andel et al. LEUKEMIA
- A Niche-Dependent Myeloid Transcriptome Signature Defines Dormant Myeloma Cells
- (2019) Weng Hua Khoo et al. BLOOD
- A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia
- (2019) Ninib Baryawno et al. CELL
- Exosome-Mediated Metastasis: Communication from a Distance
- (2019) Inbal Wortzel et al. DEVELOPMENTAL CELL
- Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model
- (2019) Alessandro Natoni et al. HAEMATOLOGICA
- Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3
- (2019) Puglisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
- (2019) M. Frenquelli et al. LEUKEMIA
- In the Right Place, at the Right Time: Spatiotemporal Conditions Determining Plasma Cell Survival and Function
- (2019) Randall L. Lindquist et al. Frontiers in Immunology
- CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
- (2019) Alberto L. Horenstein et al. Frontiers in Immunology
- Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
- (2019) Maria-Victoria Mateos et al. Lancet Haematology
- Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
- (2019) Saad Zafar Usmani et al. Lancet Haematology
- JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression
- (2019) Haiming Chen et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models
- (2019) Bjarne Bogen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo
- (2019) Khatora S. Opperman et al. NEOPLASIA
- How to Train your T cells: Overcoming Immune Dysfunction in Multiple Myeloma
- (2019) Adam D Cohen et al. CLINICAL CANCER RESEARCH
- Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
- (2019) Juan-Jose Garcés et al. LEUKEMIA
- CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma
- (2019) Ruyi Xu et al. Cell Death & Disease
- Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
- (2019) Amy J. Petty et al. Cells
- Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
- (2019) Laura Lorenzo-Sanz et al. Cancer Microenvironment
- The microenvironment in myeloma
- (2019) Oliver C. Lomas et al. CURRENT OPINION IN ONCOLOGY
- Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
- (2018) Satoshi Takagi et al. CLINICAL CANCER RESEARCH
- Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow
- (2018) Konrad Haberland et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- No strict requirement for eosinophils for bone marrow plasma cell survival
- (2018) Alexandra Bortnick et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy
- (2018) Alessandra Romano et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Niches for Hematopoietic Stem Cells and Their Progeny
- (2018) Qiaozhi Wei et al. IMMUNITY
- Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression
- (2018) Yawara Kawano et al. JOURNAL OF CLINICAL INVESTIGATION
- Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
- (2018) Song Xu et al. LEUKEMIA
- The bone-marrow niche in MDS and MGUS: implications for AML and MM
- (2018) Irene M. Ghobrial et al. Nature Reviews Clinical Oncology
- Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space
- (2018) O. Akinduro et al. Nature Communications
- Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
- (2018) Prajakta Shinde et al. Scientific Reports
- Quantitative and functional alterations of 6-sulfo LacNac dendritic cells in multiple myeloma
- (2018) Baptiste Lamarthée et al. OncoImmunology
- Myeloma-escape after stem cell transplantation is a consequence of T cell exhaustion and is prevented by TIGIT blockade
- (2018) Simone A. Minnie et al. BLOOD
- APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications
- (2018) Yu-Tzu Tai et al. LEUKEMIA
- Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion
- (2018) Doan C. Nguyen et al. Nature Communications
- Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity
- (2018) Marte Fauskanger et al. Frontiers in Immunology
- Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study
- (2018) Ji-nuo Wang et al. Cancer Cell International
- Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment
- (2018) Jihao Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
- (2018) Mathilde Mathieu et al. NATURE CELL BIOLOGY
- Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation
- (2017) Nathan De Beule et al. JOURNAL OF PATHOLOGY
- A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells
- (2017) A Ray et al. LEUKEMIA
- Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma
- (2017) Q Wang et al. LEUKEMIA
- Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma
- (2017) Xinyi Chen et al. Oncotarget
- T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
- (2017) Arielle Glatman Zaretsky et al. Cell Reports
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Hematopoietic Stem Cell Niche in Health and Disease
- (2016) Jonathan Hoggatt et al. Annual Review of Pathology-Mechanisms of Disease
- Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
- (2016) A. Gutierrez-Gonzalez et al. BLOOD
- The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
- (2016) V. Hoyos et al. BLOOD
- Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
- (2016) J. Krejcik et al. BLOOD
- Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
- (2016) Sung-Eun Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma
- (2016) Gordana Konjević et al. JOURNAL OF CLINICAL PATHOLOGY
- T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
- (2016) Claudia Zelle-Rieser et al. Journal of Hematology & Oncology
- Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy
- (2016) Ofrat Beyar-Katz et al. JOURNAL OF PATHOLOGY
- Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression
- (2016) Jinheng Wang et al. JOURNAL OF PATHOLOGY
- Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response
- (2016) Yuhuan Zheng et al. JNCI-Journal of the National Cancer Institute
- Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade
- (2016) H Suen et al. LEUKEMIA
- Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates With Progression of Human Myeloma
- (2016) Alberto L Horenstein et al. MOLECULAR MEDICINE
- Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment
- (2016) Lei Dong et al. NATURE
- Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)
- (2016) Cesarina Giallongo et al. Oncotarget
- Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response
- (2016) Yuhuan Zheng et al. JNCI-Journal of the National Cancer Institute
- Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing
- (2015) P. Leone et al. BLOOD
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens
- (2015) A. A. Tveita et al. CANCER RESEARCH
- Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment
- (2015) A. Ponzetta et al. CANCER RESEARCH
- Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
- (2015) G. Gorgun et al. CLINICAL CANCER RESEARCH
- The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients
- (2015) Rodanthi Vyzoukaki et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma
- (2015) S Panchabhai et al. LEUKEMIA
- In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins
- (2015) M Martínez-Moreno et al. LEUKEMIA
- The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma
- (2015) Morten N. Andersen et al. LEUKEMIA RESEARCH
- Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma
- (2015) Michael G. Alexandrakis et al. PATHOLOGY & ONCOLOGY RESEARCH
- Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
- (2015) Michelle A. Lawson et al. Nature Communications
- Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients
- (2015) S Yousef et al. Blood Cancer Journal
- Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma
- (2015) Yi Li et al. Oncotarget
- The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
- (2015) Jinheng Wang et al. Oncotarget
- Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells
- (2015) Kim De Veirman et al. Oncotarget
- Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation
- (2015) Lavinia Raimondi et al. Oncotarget
- Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype
- (2015) Katia Beider et al. Oncotarget
- Osteoblastic niche supports the growth of quiescent multiple myeloma cells
- (2014) Z. Chen et al. BLOOD
- The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma
- (2014) S. V. Glavey et al. BLOOD
- Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
- (2014) J. Wang et al. BLOOD
- Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
- (2014) T. Umezu et al. BLOOD
- Tumor-induced CD14+HLA-DR−/low myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients
- (2014) Zhitao Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells
- (2014) Sandra Zehentmeier et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Indirect CD4+T-cell-mediated elimination of MHC IINEGtumor cells is spatially restricted and fails to prevent escape of antigen-negative cells
- (2014) Anders A. Tveita et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting the bone marrow microenvironment in multiple myeloma
- (2014) Yawara Kawano et al. IMMUNOLOGICAL REVIEWS
- Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs
- (2014) Allison L. Boyd et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma
- (2014) James Favaloro et al. LEUKEMIA & LYMPHOMA
- Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells
- (2014) Meng Zhao et al. NATURE MEDICINE
- Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion
- (2014) Ingmar Bruns et al. NATURE MEDICINE
- Shp1 signalling is required to establish the long-lived bone marrow plasma cell pool
- (2014) Yan-Feng Li et al. Nature Communications
- Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6
- (2013) M. Witzens-Harig et al. BLOOD
- Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells
- (2013) T. Tanno et al. BLOOD
- Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning
- (2013) T. S. Olson et al. BLOOD
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1
- (2013) L Mirandola et al. LEUKEMIA
- Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib
- (2013) H A F Stessman et al. LEUKEMIA
- Arteriolar niches maintain haematopoietic stem cell quiescence
- (2013) Yuya Kunisaki et al. NATURE
- Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration
- (2013) Daniel Lucas et al. NATURE MEDICINE
- Induction of Malignant Plasma Cell Proliferation by Eosinophils
- (2013) Tina W. Wong et al. PLoS One
- Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance
- (2013) C Bryant et al. Blood Cancer Journal
- A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
- (2013) Alberto L Horenstein et al. OncoImmunology
- Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
- (2013) Simona Berardi et al. Journal of Oncology
- FGF signaling facilitates postinjury recovery of mouse hematopoietic system
- (2012) M. Zhao et al. BLOOD
- Myeloma as a model for the process of metastasis: implications for therapy
- (2012) I. M. Ghobrial BLOOD
- The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
- (2012) K Giannopoulos et al. BRITISH JOURNAL OF CANCER
- Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
- (2012) Jaehyup Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- The establishment of the plasma cell survival niche in the bone marrow
- (2012) Van T. Chu et al. IMMUNOLOGICAL REVIEWS
- Molecular pathogenesis of multiple myeloma and its premalignant precursor
- (2012) W. Michael Kuehl et al. JOURNAL OF CLINICAL INVESTIGATION
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
- (2012) Giuseppina Bonanno et al. Journal of Translational Medicine
- Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells
- (2012) M Bolzoni et al. LEUKEMIA
- PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma
- (2012) Y Zheng et al. LEUKEMIA
- Pathogenesis of Myeloma
- (2011) Kenneth C. Anderson et al. Annual Review of Pathology-Mechanisms of Disease
- Integrin 7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
- (2011) P. Neri et al. BLOOD
- P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment
- (2011) A. K. Azab et al. BLOOD
- The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
- (2011) Klaus Podar et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
- (2011) J. Stagg et al. CANCER RESEARCH
- Nonmyelinating Schwann Cells Maintain Hematopoietic Stem Cell Hibernation in the Bone Marrow Niche
- (2011) Satoshi Yamazaki et al. CELL
- Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma
- (2011) Noopur Raje et al. CLINICAL CANCER RESEARCH
- Bone marrow CD169+macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
- (2011) Andrew Chow et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
- (2011) Jacalyn Rosenblatt et al. JOURNAL OF IMMUNOTHERAPY
- Eosinophils are required for the maintenance of plasma cells in the bone marrow
- (2011) Van Trung Chu et al. NATURE IMMUNOLOGY
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow
- (2010) O. Winter et al. BLOOD
- Canonical BMP signaling is dispensable for hematopoietic stem cell function in both adult and fetal liver hematopoiesis, but essential to preserve colon architecture
- (2010) S. Singbrant et al. BLOOD
- A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
- (2010) K. Noonan et al. BLOOD
- Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs
- (2010) I. G. Winkler et al. BLOOD
- Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
- (2010) R. H. Prabhala et al. BLOOD
- Osteoblast function in myeloma
- (2010) G. David Roodman BONE
- Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
- (2010) Keiyo Takubo et al. Cell Stem Cell
- The Essential Functions of Adipo-osteogenic Progenitors as the Hematopoietic Stem and Progenitor Cell Niche
- (2010) Yoshiki Omatsu et al. IMMUNITY
- Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts
- (2010) Maciej Tarnowski et al. MOLECULAR CANCER RESEARCH
- Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
- (2010) Simón Méndez-Ferrer et al. NATURE
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
- (2009) Y. Zheng et al. BLOOD
- Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
- (2009) M Garayoa et al. LEUKEMIA
- Canonical Notch Signaling Is Dispensable for the Maintenance of Adult Hematopoietic Stem Cells
- (2008) Ivan Maillard et al. Cell Stem Cell
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Endochondral ossification is required for haematopoietic stem-cell niche formation
- (2008) Charles K. F. Chan et al. NATURE
- Haematopoietic stem cell release is regulated by circadian oscillations
- (2008) Simón Méndez-Ferrer et al. NATURE
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells
- (2008) Angela Colmone et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now